MDS Highlights

flipper_slider

Editor's Choice

Rajesh Pahwa reviews the current unmet needs in Parkinson’s Disease Psychosis and available treatment options. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE...

MDS Highlights Videos

Fabrizio Stocchi discusses how OFF periods develop during Levodopa therapy and the use of apomorphine therapy to address these OFF periods. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 CAN YOU EXPLAIN HOW OFF PERIODS DEVELOP DURING...
Daniela Berg discusses the initiation of pharmacological treatment and the progress that has been made into finding biomarkers of neurodegeneration in early stage Parkinson’s disease. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 WHEN...
Daniela Berg talks about the recently updated clinical diagnostic criteria for Parkinson’s disease produced by the MDS Task Force on Definition of Parkinson's Disease. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 THE MDS TASK FORCE ON...
Amos D Korczyn discusses the development and assessment of non-motor symptoms in Parkinson’s disease and how cognitive decline can be treated. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 AT WHAT STAGE OF PARKINSON’S DISEASE DO NON-...
Rajesh Pahwa reviews the current unmet needs in Parkinson’s Disease Psychosis and available treatment options. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 HOW PREVALENT IS PSYCHOSIS IN PARKINSON’S DISEASE? 00:10 – Parkinson’s...
Wolfgang Jost discusses the latest treatment and diagnosis approaches in cervical dystonia. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 WHAT RECENT ADVANCES HAVE BEEN MADE IN THE USE OF BOTULINUM TOXIN IN THE TREATMENT OF CERVICAL...
Olivier Rascol discusses catechol-O-methyltransferase (COMT) inhibitor use in Parkinson’s Disease and the latest clinical findings on opicapone. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 HOW ARE THE CATECHOL-O-METHYLTRANSFERASE (COMT...
Stuart Isaacson describes the advantages of the DaT SPECT imaging technique. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 COULD YOU TELL US ABOUT THE DAT SPECT IMAGING TECHNIQUE? 00:10 – DaTscan imaging is a way of looking at the...
Alberto Albanese discusses the current unmet needs in dystonia and spasticity and the promising new treatments currently in development. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 WHAT ARE THE CURRENT UNMET NEEDS IN THE TREATMENT OF...